Klinea BioPharmaceutical Engineering is #Biotech 25/09/2024 Healthcare Advanced therapies Klinea, part of an innovation ecosystem in Advanced Therapies. Partners - Klinea Biotech & Pharma Engineering
Vafidemstat emerges as a promising treatment for Borderline Personality Disorder 24/09/2024 Healthcare Advanced therapies Oryzon Genomics, a clinical-stage biopharmaceutical company, is advancing vafidemstat, its LSD1 inhibitor for CNS... Partners - Oryzon Genomics
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop... AseBio
Revolutionary CAR-T Cell Therapies: A New Era in Cancer Treatment 17/09/2024 Healthcare Advanced therapies Promega's contribution to the development and verification of genetically modified CAR-T cells is driving innovation in... Partners - Promega
Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com... 15/09/2024 Healthcare Rare diseases Personalized medicine Advanced therapies It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority... AseBio
NLRP3: From Scientific Curiosity to Therapeutic Efficacy 04/09/2024 Healthcare Personalized medicine Advanced therapies Joaquín Gómez Moya, executive president of Viva in Vitro, explains in this forum the important role of the NLRP3... Partners - VIVA IN VITRO
Peaches Biotech ready to enter into the production of biological medicines with the Histok... 06/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located in the Basque Country... Partners - PEACHES BIOTECH S.L.
ORYZON reports financial results and corporate update for half-year ending June 30, 2024 01/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a result of the completion... Partners - Oryzon Genomics
Integra Therapeutics to receive up to €10.5 million from European Commission for its FiCAT... 17/07/2024 Healthcare Access to innovation Rare diseases Advanced therapies EU projects This funding will enable Integra Therapeutics to launch its first gene therapy to treat a serious pediatric hepatic... Partners - Integra Therapeutics S.L.
